Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less-Reference-Cited by-同舟云学术

Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less

Published:2022-03-14 Issue:5 Volume:18 Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Marumo Atsushi¹²^ORCID,Omori Ikuko²,Tara Shuhei³,Otsuka Yuki¹,Konuma Ryosuke¹,Adachi Hiroto¹,Wada Atsushi¹,Kishida Yuya¹,Konishi Tatsuya¹,Nagata Akihito¹,Yamada Yuta¹,Nagata Ryohei¹,Noguchi Yuma¹,Toya Takashi¹,Igarashi Aiko¹,Najima Yuho¹,Kobayashi Takeshi¹,Yamaguchi Hiroki²^ORCID,Inokuchi Koiti²,Sakamaki Hisashi¹,Ohashi Kazuteru¹,Doki Noriko¹^ORCID

Affiliation:

1. Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

2. Department of Hematology Nippon Medical School Tokyo Japan

3. Division of Cardiovascular Intensive Care Unit Nippon Medical School Tokyo Japan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13674

Reference26 articles.

1. HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide